Claudia Health Tracker

Latest panel — Oct 9 2026

Goodlabs/Quest · 122 markers · Collected 2026-10-09

Values and statuses exactly as supplied by the source. Not provided means the supplied value was blank. N/A and SEE NOTE: remain literal source text; no additional note was supplied.

Marker	Reported value	Separate unit	Source status
PTFQI	0.47 {Index_val}		Poor
FT3/FT4 Ratio	0.28 ratio		Poor
SPINA-GT	3.61 pmol/s		Optimal
SPINA-GD	26.1 nmol/s		Optimal
Ferritin (Adj. for Inflammation)	142.68 ng/mL		Poor
RW-ApoB	75.2 mg/dL		Optimal
eGFR (creatinine + cystatin C)	78.26 mL/min/1.73m2		Normal
Anion Gap	12 mmol/L		In Range
UIBC	140 ug/dL		In Range
Testosterone:Cortisol Ratio	Not provided
Triglyceride/HDL Ratio	1.41 ratio		Optimal
LDL/HDL Ratio	2 ratio		Optimal
Copper (Serum)	88 ug/dL		In Range
Zinc (Serum)	69 ug/dL		In Range
Lead (Blood)	<1	ug/dL	Optimal
Mercury (Blood)	<4	ug/L	Optimal
LDL Particle Number	853 nmol/L		Normal
Small LDL Particle Number	153 nmol/L		In Range
Medium LDL Particle Number	199 nmol/L		In Range
HDL Large Particle Number	5809 nmol/L		Out of Range
LDL Pattern	A	pattern
LDL Size	218 Å		Poor
Leptin	1.9 ng/mL		In Range
Methylmalonic Acid (MMA)	250 nmol/L		Poor
TPOAb	5 IU/mL		In Range
Estradiol, Ultrasensitive (LC/MS)	69 pg/mL		Out of Range
Free Testosterone (Calculated)	321.1 pg/mL		Poor
Testosterone (Bioavailable)	604.4 ng/dL		Out of Range
TgAb	<2	IU/mL	In Range
EPA + DPA + DHA	4.3 %		Out of Range
Arachidonic Acid/EPA Ratio	20.6 ratio		In Range
Omega-6/Omega-3 Ratio	8.6 ratio		Normal
Omega-3 Total	4.3 %		In Range
EPA	0.6 %		In Range
DPA	1.2 %		In Range
DHA	2.6 %		In Range
Omega-6 Total	36.7 %		In Range
Arachidonic Acid	11.7 %		In Range
Linoleic Acid	20.8 %		In Range
Testosterone (Total)	1516 ng/dL		Urgent
Homocysteine	9.5 umol/L		Poor
Cystatin C	0.99 mg/L		In Range
eGFR (cystatin C)	83 mL/min/1.73m2		Normal
SHBG	30 nmol/L		In Range
Insulin (Fasting)	3.2 uIU/mL		Optimal
TSH	1.68 uIU/mL		Optimal
T4 Free	1.4 ng/dL		Optimal
T3 Free	3.3 pg/mL		In Range
ANA Screen	POSITIVE		Poor
ANA Titer	1:80	titer
ANA Pattern	Nuclear, Speckled	pattern
DHEA-S	228 ug/dL		In Range
PSA (Total)	0.7 ng/mL		In Range
PSA (Free)	N/A	ng/mL
PSA (Free) Percentage	43 %		In Range
Ferritin	207 ng/mL		Poor
Vitamin D (25-OH)	52 ng/mL		In Range
Cortisol (AM Serum)	9.1 ug/dL		In Range
FSH	<0.7	mIU/mL	Out of Range
LH	0.2 mIU/mL		Out of Range
Prolactin	8.4 ng/mL		In Range
ApoB	86 mg/dL		Normal
Lp(a)	13 nmol/L		Optimal
RF	<10	IU/mL	In Range
hs-CRP	4 mg/L		Poor
Serum Iron	75 ug/dL		In Range
TIBC	215 ug/dL		Out of Range
Transferrin Saturation (TSAT)	35 %		Optimal
Creatinine, Urine	220 mg/dL		In Range
Microalbumin Urine	N/A	mg/dL
Albumin/Creatinine Ratio, Urine	1 mg/g creat		Optimal
Total Cholesterol	163 mg/dL		In Range
HDL-Cholesterol	49 mg/dL		Normal
Triglycerides	69 mg/dL		Optimal
LDL-Cholesterol	98 mg/dL		Normal
Total Cholesterol/HDL Ratio	3.3 ratio		Optimal
Non-HDL Cholesterol	114 mg/dL		Normal
Glucose (Fasting)	80 mg/dL		Optimal
BUN	12 mg/dL		In Range
Creatinine	1.29 mg/dL		In Range
eGFR (creatinine)	69 mL/min/1.73m2		Normal
BUN/Creatinine Ratio	SEE NOTE:	ratio
Sodium	140 mmol/L		In Range
Potassium	4.1 mmol/L		In Range
Chloride	105 mmol/L		In Range
Carbon Dioxide	23 mmol/L		In Range
Calcium (Total)	9.3 mg/dL		In Range
Total Protein	6.3 g/dL		In Range
Albumin	4.1 g/dL		In Range
Globulin	2.2 g/dL		In Range
Albumin/Globulin Ratio	1.9 ratio		In Range
Total Bilirubin	0.4 mg/dL		In Range
ALP	44 U/L		In Range
AST	14 U/L		Optimal
ALT	16 U/L		Optimal
Magnesium (Serum)	2 mg/dL		In Range
Uric Acid	5.3 mg/dL		Optimal
GGT	28 U/L		In Range
Amylase	35 U/L		In Range
Lipase	16 U/L		In Range
HbA1c	5.1 %		Optimal
Ceruloplasmin	22 mg/dL		In Range
WBC	8.6 K/uL		In Range
MCV	94.7 fL		In Range
MCH	31.2 pg		In Range
MCHC	32.9 g/dL		In Range
RDW (RDW-CV)	12.1 %		In Range
Platelet Count	259 K/uL		In Range
MPV	11.3 fL		In Range
Absolute Neutrophils	5401 cells/uL		In Range
Absolute Lymphocytes	2227 cells/uL		In Range
Absolute Monocytes	791 cells/uL		In Range
Absolute Eosinophils	120 cells/uL		In Range
Absolute Basophils	60 cells/uL		In Range
Neutrophils (%)	62.8 %		In Range
Lymphocytes (%)	25.9 %		In Range
Red Blood Cell Count	4.49 million/uL		In Range
Hemoglobin	14 g/dL		In Range
Hematocrit	42.5 %		In Range
Monocytes (%)	9.2 %		In Range
Eosinophils (%)	1.4 %		In Range
Basophils (%)	0.7 %		In Range

Historical Executive Summary

Jul 29 2026

Mixed — lipids are the real story; hormones are explained

Key Findings

Cardiovascular is now the headline, not the hormones. LDL-C 173, non-HDL 195, ApoB 132, LDL particle number 1,955 (optimal <1,138), small dense LDL 535 (optimal <142), Pattern B. Five independent measures pointing the same direction. ApoB rose from 93 in Apr 2026 to 132 in Jul 2026 — a 42% increase in four months.
Testosterone 224 ng/dL — expected suppression, not a crash. Drawn after several weeks off exogenous testosterone (current 250 mg/week). LH 0.6 and FSH 1.1 confirm HPTA shutdown from TRT. Prolactin normal at 6.5 rules out the main pituitary pathology. Free T 24.7 pg/mL and bioavailable T 50.9 track the same washout. Not pathological secondary hypogonadism.
Homocysteine 16.4 µmol/L — and now we know why it is not B12. Methylmalonic acid is normal at 248 nmol/L, which is the functional tissue test for B12. So this is folate, B6, MTHFR methylation, or the kidney — not cobalamin. Changes which supplement actually matters.
Omega-3 is the cheapest fix on the panel. Index 2.9% (target >5.4%), EPA 0.2% by weight, AA/EPA ratio 59.1 against a ceiling of 40.7. One intervention moves triglycerides, hsCRP, and the AA/EPA ratio simultaneously.
Kidney: reassuring on the detail. Creatinine 1.40 and eGFR 63 look like Stage 2 CKD, but urine albumin/creatinine is 2 mg/g (ref <30) — no protein leak — and BUN is normal at 16. In a lean muscular male this is far more likely creatinine generation from muscle mass than filtration failure. Cystatin C would settle it definitively.
ANA positive 1:80 speckled — low positive. Roughly a quarter of healthy adults test positive at this titer. Rheumatoid factor negative, TPO antibodies negative. Only meaningful if symptomatic.
Lp(a) 27 nmol/L — optimal. The inherited, unmodifiable slice of cardiovascular risk is low. Genuinely good news, and a once-in-a-lifetime test now banked.
Metabolic health remains excellent. Glucose 81, HbA1c 5.0%, insulin 3.7 µIU/mL. Best numbers in the 22-year record. Whatever you are doing on that front, keep doing it.

Priority Actions

HIGH Take the lipid panel to a physician. ApoB 132 with LDL-P 1,955, small dense LDL 535 and Pattern B is the one cluster on this report that changes long-term outcome. Ask specifically about the ApoB trajectory 93 → 132 in four months.
HIGH Omega-3: 2-3 g combined EPA+DHA daily. Single highest-yield intervention on the panel — moves omega-3 index, AA/EPA ratio, hsCRP and triglycerides together. Recheck OmegaCheck in 3 months.
HIGH Homocysteine: methylfolate + P5P (B6) + riboflavin + TMG. Skip the high-dose B12 — MMA at 248 nmol/L shows B12 status is fine. Retest in 6-8 weeks.
MEDIUM Request cystatin C to resolve the creatinine/eGFR question properly. It is unaffected by muscle mass, unlike creatinine.
MEDIUM Retest triglycerides trend — 410 mg/dL in Aug 2025 vs 100 mg/dL now. That is a tenfold swing between draws and worth understanding.
LOW Testosterone: no endocrine workup needed. If resuming TRT, nothing to do. If staying off, retest total T, free T, LH and FSH at 8-12 weeks to confirm HPTA recovery.
LOW ANA: no action without symptoms. If joint pain, rash, dry eyes/mouth or Raynaud's appear, repeat with ENA panel, anti-dsDNA, C3/C4 and ESR.

Historical Context

Testosterone trajectory: May 2023 (310, baseline) → Aug 2023 (467) → Jul 2024 (730) → Jan 2025 (1,370 peak, on-cycle) → Aug 2025 (1,116, on-cycle) → Apr 2026 (900) → Jul 2026 (224, drawn several weeks off testosterone; current resumed dose is 250 mg/week). The Jul 2026 value reflects expected HPTA suppression during washout, not endogenous decline.

ApoB tells the more important story: Aug 2023 (125) → Jul 2024 (128) → Aug 2025 (135) → Apr 2026 (93) → Jul 2026 (132). The Apr 2026 dip to 93 was the outlier, not the rule; the underlying trend is a stable-to-rising atherogenic particle count across three years. Combined with the newly measured LDL-P of 1,955 and small dense LDL of 535, this is the finding on the report most worth a clinician conversation.

Oura

2026-11-02T20:00:48Z · oura-api

Readiness

2026-10-2774

Sleep

2026-10-2775

Activity

2026-10-2782

Heart rate

2026-10-2772 bpm

72 bpm

Active calories

2026-10-27216/500

216/500

Date	Readiness	Sleep	Activity	HR	Active kcal	Source
2026-10-27	74	75	82	72	216	oura-api
2026-10-26	65	78	90	76	414	oura-api
2026-10-25	55	61	91	84	291	oura-api
2026-10-24	74	71	93	62	899	oura-api
2026-10-23	67	58	90	62	208	oura-api
2026-10-22	61	55	80	64	359	oura-api
2026-10-21	47	48	83	74	585	oura-api
2026-10-20	—	—	86	66	569	oura-api
2026-10-19	54	73	85	83	464	oura-api

Current Supplement Stack

Day/night split agreed 24 Aug 2026 · reviewed 26 Aug

Protocol start (night stack): 24 Aug 2026 ~00:04 UTC 25 Aug. Ian confirmed first night dose taken. Use this date against the next bloods — especially homocysteine (retest ~6 weeks, ~5 Oct 2026) and omega-3 index (recheck ~3 months, ~24 Nov 2026). Physical inventory from photos 24 August 2026. 36 products on the shelf. This is what is in stock, not a new prescription.

☀️ Day — With Breakfast

Bupropion XL 300 mg — 1 tablet each morning ScieGen
Vitamin D3 + K2 — 1 tablet (4000 IU + 100 µg MK-7) Nutrition Geeks
CoQ10 Ubiquinol — 1 softgel (200 mg) HTN
Vitamin B Complex — 1 tablet WeightWorld
L-Methylfolate 400 µg — 1 capsule Health Leads
TMG 1000 mg — 1 capsule NutriONN
P5P 50 mg — 1 capsule Health4All
Vitamin B12 1000 µg — 1 capsule Health Leads; confirm methyl form
NAC 600 mg — 1 capsule New Leaf
Lion's Mane Focus+ — 1–2 tablets Nutrition Geeks
Turmeric + Black Pepper — 1 tablet Nutrition Geeks
Acetyl-L-Carnitine 500 mg — 1 capsule
Alpha Lipoic Acid 600 mg — 1 capsule with food
Citicoline 500 mg — 1 capsule
Berberine 500 mg — 1 capsule skip on low-food / retatrutide days
Ginkgo + Siberian Ginseng — 1 tablet Ian added to daily morning 24 Aug 2026

🌙 Night — Before Bed

Fish Oil 4 capsules — EPA 660 / DHA 440 per 2 moved to night 24 Aug 2026; with food, not empty
Magnesium Glycinate — 2 tablets (400 mg elemental + B6)
Ashwagandha KSM-66 600 mg — 1 capsule
L-Theanine 400 mg — 1 capsule
Phosphatidylserine 300 mg — 1 capsule
PQQ 20 mg — 1 capsule
Zinc Picolinate 50 mg — 1 capsule with food
Selenium 200 µg — 1 tablet
Atorvastatin 40 mg — 1 tablet
Tadalafil (Cialis) 5 mg — 1 tablet moved to night 24 Aug 2026

As-Needed / Rotate

Methylene Blue 1% — occasional, 2–4 drops sublingual not with bupropion
Pantozol 20 mg — only if reflux
Duspatalin 200 mg — only if IBS/gut
Anastrozole 1 mg — only if estrogen spikes on TRT
Bulk electrolytes — Na 1034 / K 306 / Ca 184 mg per 2 servings
LMNT Mango Chili — Na/K/Mg not visible on photo

Injectables / research-labelled

Testosterone Enanthate — 250 mg/week current figure confirmed 26 Aug 2026; supersedes older 300 mg every 7–10 days
NAD+ 1000 mg vial — 100–200 mg subcutaneous
Retatrutide 20 mg vial — start 0.5–1 mg/week, titrate slowly
Oxandrolone 10 mg — bottle now on the shelf; no standing dose set from this inventory

HGH assessment — advisory notes

26 Aug 2026

This records Ian’s pasted assessment; it is not approval or an instruction to start HGH. The July labs largely predate the current resumed testosterone dose (250 mg/week) and any HGH. Establish a fresh baseline with a prescriber rather than assuming those values are unchanged.

Current read

Liver reassuring: 29 Jul ALT 20, AST 15, GGT 40 U/L, albumin 4.6 g/dL and bilirubin 0.8 mg/dL. No biochemical evidence of current liver injury. HGH is not generally considered conventionally hepatotoxic; monitor the full stack. Ashwagandha 600 mg/day remains a rare but documented liver-injury consideration if markers change.
Kidney needs clarification: creatinine 1.40 mg/dL and creatinine-eGFR 63, with reassuring BUN 16 and urine ACR 2 mg/g. Cystatin C + eGFR is the key pre-HGH clarification because muscle mass can elevate creatinine and GH/IGF-1 can alter renal blood flow/filtration.
Glucose baseline excellent: fasting glucose 81 mg/dL, fasting insulin 3.7 µIU/mL and HbA1c 5.0%. HGH can reduce insulin sensitivity; retatrutide, berberine, ALA and weight loss should not be assumed to prevent that. The exact HGH + retatrutide combination lacks good trial data.
Testosterone + fluid/red cells: July Hb 16.4 g/dL and Hct 48.9% were acceptable but largely before the current resumed 250 mg/week testosterone. HGH can cause dose-dependent fluid retention, edema, arthralgia, paresthesias and carpal-tunnel-type symptoms. Latest BP was 117/77 on 15 Aug; earlier 143/45 was not reproduced.
Zinc/copper: zinc picolinate 50 mg nightly exceeds the adult tolerable upper intake level of 40 mg/day. Prolonged use can impair copper absorption; add serum copper + ceruloplasmin to the next draw.
Planned surgery: non-prescribed complementary/herbal products are commonly stopped about two weeks before planned surgery, especially turmeric/piperine, ginkgo/ginseng, ashwagandha, fish oil and other nonessential supplements. Follow the surgeon/anaesthetist’s exact instructions.

Baseline before any clinician-directed HGH

IGF-1 with age-adjusted reference range and Z-score
Cystatin C + cystatin-C-derived eGFR
Fasting glucose + fasting insulin
CBC, haemoglobin and haematocrit
ALT, AST, GGT and bilirubin
Blood pressure + morning body weight
Serum copper + ceruloplasmin

Suggested follow-up if prescribed

At about 3–4 weeks, repeat IGF-1, fasting glucose/insulin, CBC/haematocrit, renal markers including cystatin C, BP and morning body weight. Confirm timing and scope with the prescriber.

Risk emphasis from this assessment: current liver risk appears low; direct kidney-toxicity risk is probably low but filtration is unresolved; the main monitoring issues are insulin sensitivity, fluid/BP, renal filtration and IGF-1 overshoot.

Inventory log — 36 products

Stamped 24 Aug 2026 13:11 UTC

What changed vs the last site stack

Now in hand for homocysteine: TMG 1000 mg, P5P 50 mg, B12 1000 µg, methylfolate 400 µg already here since 20 Aug.
New bottles: Bupropion XL 300 mg (1 morning), oxandrolone 10 mg, Bulk electrolytes, LMNT.
Not in the photos: folic acid 5 mg, NMN, astaxanthin, cortisol balance, lithium, vitamin C, HGH, red yeast rice.
Still open: B12 form not labelled. Omega-3 still at 2 caps (~1.1 g EPA+DHA) vs the 2–3 g protocol.

Counts

Nutritional / electrolytes: 25
Prescription / medicinal: 6 — Bupropion, Cialis, Pantozol, Duspatalin, Atorvastatin, Anastrozole
Hormonal / anabolic: 2 — Testosterone Enanthate, Oxandrolone
Research-labelled: 2 — NAD+, Retatrutide
Other: 1 — Methylene Blue 1%

Adjust Stack Based on Bloods

Tailoring Guide

Lipid Profile

High LDL/ApoB: Add Red Yeast Rice 1200mg or Bergamot 500-1000mg. Increase fish oil to 3-4g EPA+DHA.
Low HDL: Ensure fish oil at 2-3g. Add niacin 500mg (under supervision) if HDL <40.
High Triglycerides: Increase fish oil to 4g EPA+DHA. Eliminate refined carbs and alcohol.
High Homocysteine: Ensure methylfolate (not folic acid), methylcobalamin, P5P are in stack. Add TMG 500-1000mg.

Vitamins & Minerals

Low Vitamin D (<40): Increase D3 to 5000 IU daily. Ensure K2 paired.
Low B12 (<500): Add methylcobalamin 2000mcg sublingual.
Low Folate: Switch to methylfolate if on folic acid.
Low Magnesium (RBC <5.0): Increase glycinate to 400-600mg.
Low Zinc: Add zinc picolinate 30-50mg with copper 2mg.

Liver Function

Elevated ALT/AST: Increase NAC to 1200mg. Add milk thistle 500mg. Reduce alcohol.
High GGT: Indicates liver stress — NAC, reduce alcohol, check medications.
Low Albumin: Ensure adequate protein intake (1.6-2g/kg).

Kidney Function

Elevated Creatinine/Low eGFR: Hydration 3+ L/day critical. Avoid NSAIDs. Consider reducing protein if >2.5g/kg. Add astragalus 500-1000mg.
High Uric Acid: Reduce purines (red meat, organ meats, shellfish). Tart cherry extract 500mg.

Hematocrit / Red Cells

High Hematocrit (>50%): Common on TRT. Donate blood if >52%. Stay hydrated. Naringin 500mg may help.
High Ferritin (>300): Donate blood. Do not supplement iron.
Low Hemoglobin: Check iron, B12, folate. Rarely an issue on TRT.

Historical Watchlist — Jul 29 2026

Marker	Status	Details
ApoB (mg/dL)	HIGH	132 mg/dL (optimal <90, high ≥130). Up from 93 in Apr 2026. Best single predictor of cardiovascular events.
LDL Particle Number (nmol/L)	HIGH	1,955 nmol/L (optimal <1,138; high >1,409). Confirms the ApoB signal independently.
LDL Small (nmol/L)	HIGH	535 nmol/L (optimal <142; high >219). Most atherogenic LDL fraction. Pattern B phenotype.
LDL Cholesterol (mg/dL)	HIGH	173 mg/dL (ref <100). Non-HDL 195 mg/dL (ref <130).
EPA+DPA+DHA (Omega-3)	LOW	2.9% (ref >5.4%). EPA 0.2% by wt. AA/EPA ratio 59.1 (ref 3.7-40.7). Severely pro-inflammatory.
Homocysteine (umol/L)	HIGH	16.4 µmol/L (ref ≤13.5). MMA normal at 248 — so this is folate/B6/MTHFR, not B12.
Testosterone (ng/dL)	EXPECTED	224 ng/dL (ref 250-1100) with LH 0.6 / FSH 1.1. Expected HPTA suppression from TRT washout. Prolactin normal.
Creatinine / eGFR	WATCH	1.40 mg/dL, eGFR 63. But urine albumin/creatinine 2 mg/g (normal) and BUN 16 (normal) — likely muscle mass. Request cystatin C.
Uric Acid (mg/dL)	WATCH	7.5 mg/dL (ref 4.0-8.0). In range but high-normal; gout therapeutic target is <6.0.
ANA Screen	POSITIVE	1:80 speckled. Low positive — common in healthy adults. RF negative, TPO negative. No action unless symptomatic.
Lipoprotein(a) (nmol/L)	GOOD	27 nmol/L (optimal <75). Inherited CV risk is low. Never needs retesting.
Methylmalonic Acid	GOOD	248 nmol/L (ref 55-335). Rules out functional B12 deficiency.
HbA1c (%)	GOOD	5.0% (ref <5.7). Glucose 81, insulin 3.7. Best metabolic numbers in 22 years of records.
Vitamin D (ng/mL)	GOOD	48 ng/mL (ref 30-100). Up from 36. Optimal range.

Blood Pressure

Blood Pressure (mmHg)

Aug 15 2026 14:33 UTCLOW

117/77mmHg

117/77 mmHg — Normal. Pulse pressure 40 mmHg. Pulse pressure is in the healthy 30-50 mmHg band. Change since Aug 05 2026 (143/45): systolic -26, diastolic +32. Substantial improvement — the earlier elevated reading is not being reproduced. Single readings are unreliable; this is why trend matters more than any one measurement. Target: <120/80. Measure seated, arm supported at heart height, after 5 minutes rest, no caffeine or exercise in the preceding 30 minutes.

Reading	BP	Pulse pressure
Aug 15 2026 14:33 UTC	117/77	40 mmHg
Aug 05 2026 12:59 UTC	143/45	98 mmHg

Heart / lipids

Total Cholesterol (mg/dL)

Oct 9 2026

163 mg/dL

HDL Cholesterol (mg/dL)

Oct 9 2026

49 mg/dL

LDL Cholesterol (mg/dL)

Oct 9 2026

98 mg/dL

Triglycerides (mg/dL)

Oct 9 2026

69 mg/dL

ApoB (mg/dL)

Oct 9 2026

86 mg/dL

hsCRP (mg/L)

Oct 9 2026

4 mg/L

Homocysteine (umol/L)

Oct 9 2026

9.5 umol/L

EPA+DPA+DHA (% by wt)

Oct 9 2026

4.3 %

Omega-6/Omega-3 Ratio

Oct 9 2026

8.6 ratio

Non-HDL Cholesterol (mg/dL)

Oct 9 2026

114 mg/dL

LDL Particle Number (nmol/L)

Oct 9 2026

853 nmol/L

LDL Small (nmol/L)

Oct 9 2026

153 nmol/L

LDL Medium (nmol/L)

Oct 9 2026

199 nmol/L

LDL Pattern

Oct 9 2026

LDL Peak Size (Angstrom)

Oct 9 2026

218 Å

HDL Large (nmol/L)

Oct 9 2026

5809 nmol/L

Lipoprotein(a) (nmol/L)

Oct 9 2026

13 nmol/L

Chol/HDL Ratio

Oct 9 2026

3.3 ratio

AA/EPA Ratio

Oct 9 2026

20.6 ratio

EPA (% by wt)

Oct 9 2026

0.6 %

DHA (% by wt)

Oct 9 2026

2.6 %

DPA (% by wt)

Oct 9 2026

1.2 %

Arachidonic Acid (% by wt)

Oct 9 2026

11.7 %

Linoleic Acid (% by wt)

Oct 9 2026

20.8 %

Omega-6 Total (% by wt)

Oct 9 2026

36.7 %

CRP (mg/L)

Jul 28 2021

76.0▲ +75.0

Glucose / metabolism

Glucose (mg/dL)

Oct 9 2026

80 mg/dL

HbA1c (%)

Oct 9 2026

5.1 %

Insulin (µIU/mL)

Oct 9 2026

3.2 uIU/mL

Leptin (ng/mL)

Oct 9 2026

1.9 ng/mL

Hormones

Testosterone (ng/dL)

Oct 9 2026

1516 ng/dL

Free testosterone (ng/dL)

Aug 11 2025

16.14▲ +5.7

PDF free testosterone is 261 pg/mL, a different unit from CSV ng/dL; kept out of trend until converted/confirmed.

SHBG (nmol/L)

Oct 9 2026

30 nmol/L

Cortisol (µg/dL)

Oct 9 2026

9.1 ug/dL

Testosterone:Cortisol Ratio (Units)

Oct 9 2026

Not provided

FSH (mIU/mL)

Oct 9 2026

<0.7

LH (mIU/mL)

Oct 9 2026

0.2 mIU/mL

DHEA Sulfate (mcg/dL)

Oct 9 2026

228 ug/dL

PSA Total (ng/mL)

Oct 9 2026

0.7 ng/mL

Free Testosterone (pg/mL, Quest MS)

Jul 29 2026HIGH

24.7

Free testosterone 24.7 pg/mL against a Quest reference of 46.0-224.0 — low, consistent with the total of 224. Note this is a different assay and unit to the older InsideTracker free-T figures, so the two series are not directly comparable. Measured by mass spectrometry, which is the more reliable method.

Reference: 46.0-224.0 pg/mL

Bioavailable Testosterone (ng/dL)

Oct 9 2026

604.4 ng/dL

Prolactin (ng/mL)

Oct 9 2026

8.4 ng/mL

Estradiol (pg/mL)

Oct 9 2026

69 pg/mL

PSA Free (ng/mL)

Oct 9 2026

N/A

PSA % Free (%)

Oct 9 2026

43 %

Vitamins / minerals

Vitamin D (ng/mL)

Oct 9 2026

52 ng/mL

Vitamin B12 (pg/mL)

Apr 08 2026LOW

559.0▲ +211.0

B12 559 pg/mL (Apr 2026) — good level, up from 348 (Aug 2025). Optimal range often cited as 400-1,000 pg/mL. The upward trend suggests supplementation or dietary improvement. Important in context of elevated homocysteine — low B12 is a common driver. Ensure form is methylcobalamin (not cyanocobalamin) for optimal methylation support.

🧪 What to take

Methylcobalamin 1,000-2,000 mcg daily sublingual if homocysteine remains elevated

Folate (ng/mL)

Apr 08 2026LOW

13.0▲ +4.9

Folate 13.0 ng/mL (Apr 2026) — good level (ref >3 ng/mL). Up significantly from 8.1 (Aug 2025). However, serum folate doesn't always reflect intracellular folate status, especially if there's an MTHFR variant. Given elevated homocysteine despite adequate serum folate, consider switching to methylfolate (active form) which bypasses MTHFR conversion.

🧪 What to take

Switch from folic acid to methylfolate (5-MTHF) 400-800 mcg if MTHFR variant suspected

Ferritin (ng/mL)

Oct 9 2026

207 ng/mL

Iron (ug/dL)

Oct 9 2026

75 ug/dL

TIBC (ug/dL)

Oct 9 2026

215 ug/dL

Magnesium (mg/dL)

Oct 9 2026

2 mg/dL

RBC Magnesium (mg/dL)

Aug 11 2025

4.8▼ -0.9

Calcium (mg/dL)

Oct 9 2026

9.3 mg/dL

Methylmalonic Acid (nmol/L)

Oct 9 2026

250 nmol/L

Zinc (mcg/dL)

Oct 9 2026

69 ug/dL

Lead, Venous (mcg/dL)

Oct 9 2026

Transferrin saturation (%)

Oct 9 2026

35 %

Liver / kidney

ALT (U/L)

Oct 9 2026

16 U/L

AST (U/L)

Oct 9 2026

14 U/L

GGT (U/L)

Oct 9 2026

28 U/L

Albumin (g/dL)

Oct 9 2026

4.1 g/dL

Creatine kinase (U/L)

Aug 11 2025

64.0▲ +8.0

Creatinine (mg/dL)

Oct 9 2026

1.29 mg/dL

eGFR (mL/min/1.73m2)

Oct 9 2026

69 mL/min/1.73m2

Uric Acid (mg/dL)

Oct 9 2026

5.3 mg/dL

Alkaline Phosphatase (U/L)

Oct 9 2026

44 U/L

Bilirubin, Total (mg/dL)

Oct 9 2026

0.4 mg/dL

Protein, Total (g/dL)

Oct 9 2026

6.3 g/dL

Globulin (g/dL)

Oct 9 2026

2.2 g/dL

Urea Nitrogen / BUN (mg/dL)

Oct 9 2026

12 mg/dL

Albumin/Creatinine Ratio, Urine (mg/g)

Oct 9 2026

1 mg/g creat

Amylase (U/L)

Oct 9 2026

35 U/L

Lipase (U/L)

Oct 9 2026

16 U/L

Blood count / immune

Hemoglobin (g/dL)

Oct 9 2026

14 g/dL

Hematocrit (%)

Oct 9 2026

42.5 %

RBC (x10E6/µL)

Oct 9 2026

4.49 million/uL

White blood cells (thousands/uL)

Oct 9 2026

8.6 K/uL

Platelets (thousands/uL)

Oct 9 2026

259 K/uL

Neutrophil count (cells/µL)

Oct 9 2026

5401 cells/uL

Monocyte count (cells/µL)

Oct 9 2026

791 cells/uL

ANA Screen (IFA)

Oct 9 2026

POSITIVE

Rheumatoid Factor (IU/mL)

Oct 9 2026

<10

MCV (fL)

Oct 9 2026

94.7 fL

RDW (%)

Oct 9 2026

12.1 %

Lymphocyte count (cells/µL)

Oct 9 2026

2227 cells/uL

ABO Group / Rh Type

Jul 29 2026LOW

O RhD Positive

Blood group O, RhD positive.

Basophil count (cells/µL)

Oct 9 2026

60 cells/uL

Eosinophil count (cells/µL)

Oct 9 2026

120 cells/uL

MCH (pg)

Oct 9 2026

31.2 pg

MCHC (g/dL)

Oct 9 2026

32.9 g/dL

MPV (fL)

Oct 9 2026

11.3 fL

Neutrophil percentage (%)

Oct 9 2026

62.8 %

Eosinophil percentage (%)

Oct 9 2026

1.4 %

Basophil percentage (%)

Oct 9 2026

0.7 %

Lymphocyte percentage (%)

Oct 9 2026

25.9 %

Monocyte percentage (%)

Oct 9 2026

9.2 %

Thyroid

TSH (µIU/L)

Jul 29 2026LOW

1.56▼ -0.9

TSH 1.56 µIU/L — optimal (ref 0.40-4.50; functional optimal 1.0-2.5). Down from 2.42 (Apr 2026). Thyroid function appears healthy. Free T4 (1.3) and Free T3 (3.1) also within normal ranges. Thyroid is not contributing to the hormonal picture here.

T4 Free (ng/dL)

Oct 9 2026

1.4 ng/dL

T3 Free (pg/mL)

Oct 9 2026

3.3 pg/mL

Thyroid Peroxidase Ab (IU/mL)

Oct 9 2026

5 IU/mL

Thyroglobulin Ab (IU/mL)

Oct 9 2026

GI / Gut Health

FIT - Fecal Immunochemical Test

May 08 2026 GI

Negative (<15 ng/mL)

No occult blood detected. Normal: 0-100 ng/mL. Method: Latex quantitative immunochemical assay. Mediclinic Parkview Hospital.

Faecal Calprotectin (µg/g)

May 08 2026 GI

9.8

Normal <50. Borderline 50-120. Elevated >120. Measures gut inflammation. Method: CLIA. Mediclinic City Hospital.

H. pylori Antigen (Stool)

May 08 2026 GI

Negative

H. pylori antigens absent. Method: Immunochromatography. Mediclinic Dubai Mall.

Brain / electrolytes

Chloride (mmol/L)

Oct 9 2026

105 mmol/L

Carbon Dioxide (mmol/L)

Oct 9 2026

23 mmol/L

Sodium (mmol/L)

Oct 9 2026

140 mmol/L

Potassium (mmol/L)

Oct 9 2026

4.1 mmol/L

Additional panel markers

PTFQI ({Index_val})

Oct 9 2026

0.47 {Index_val}

FT3/FT4 Ratio (ratio)

Oct 9 2026

0.28 ratio

SPINA-GT (pmol/s)

Oct 9 2026

3.61 pmol/s

SPINA-GD (nmol/s)

Oct 9 2026

26.1 nmol/s

Ferritin (Adj. for Inflammation) (ng/mL)

Oct 9 2026

142.68 ng/mL

RW-ApoB (mg/dL)

Oct 9 2026

75.2 mg/dL

eGFR (creatinine + cystatin C) (mL/min/1.73m2)

Oct 9 2026

78.26 mL/min/1.73m2

Anion Gap (mmol/L)

Oct 9 2026

12 mmol/L

UIBC (ug/dL)

Oct 9 2026

140 ug/dL

Triglyceride/HDL Ratio (ratio)

Oct 9 2026

1.41 ratio

LDL/HDL Ratio (ratio)

Oct 9 2026

2 ratio

Copper (Serum) (ug/dL)

Oct 9 2026

88 ug/dL

Mercury (Blood) (ug/L)

Oct 9 2026

Free Testosterone (Calculated) (pg/mL)

Oct 9 2026

321.1 pg/mL

Omega-3 Total (%)

Oct 9 2026

4.3 %

Cystatin C (mg/L)

Oct 9 2026

0.99 mg/L

eGFR (cystatin C) (mL/min/1.73m2)

Oct 9 2026

83 mL/min/1.73m2

TSH (uIU/mL)

Oct 9 2026

1.68 uIU/mL

ANA Titer (titer)

Oct 9 2026

1:80

ANA Pattern (pattern)

Oct 9 2026

Nuclear, Speckled

Creatinine, Urine (mg/dL)

Oct 9 2026

220 mg/dL

Microalbumin Urine (mg/dL)

Oct 9 2026

N/A

BUN/Creatinine Ratio (ratio)

Oct 9 2026

SEE NOTE:

Albumin/Globulin Ratio (ratio)

Oct 9 2026

1.9 ratio

Ceruloplasmin (mg/dL)

Oct 9 2026

22 mg/dL

Appendix A — Complete Results Table

Every marker, every draw. Latest column shaded. Reference ranges as printed by the reporting laboratory.

Aug 20 2004 – May 25 2023

Marker	Aug 20 2004	Aug 12 2010	Jul 16 2014	May 18 2016	Feb 06 2017	Nov 16 2018	Jul 28 2021	May 25 2023	Reference
Heart / lipids
Total Cholesterol (mg/dL)	—	177.61	—	—	232.43	229.73	—	262
HDL Cholesterol (mg/dL)	—	45.56	—	—	63.32	53.28	—	51
LDL Cholesterol (mg/dL)	—	117.76	—	—	143.24	148.65	—	163
Triglycerides (mg/dL)	—	70.8	—	—	130.97	140.71	—	313
ApoB (mg/dL)	—	—	—	—	—	—	—	—
hsCRP (mg/L)	—	—	—	—	1	2.65	—	—
CRP (mg/L)	—	—	1	—	—	—	76	—
Glucose / metabolism
Glucose (mg/dL)	86.49	84.69	113.51	—	—	—	—	89
HbA1c (%)	—	—	—	—	5.1	5	—	5.1
Insulin (µIU/mL)	—	—	—	—	3.97	—	—	34.3
Hormones
Testosterone (ng/dL)	—	—	—	332.28	550.72	530.26	—	310
Free testosterone (ng/dL)	—	—	—	6.62	7.41	—	—	4.44	PDF free testosterone is 261 pg/mL, a different unit from CSV ng/dL; kept out of trend until converted/confirmed.
SHBG (nmol/L)	—	—	—	14.91	47.19	—	—	41.5
Cortisol (µg/dL)	—	—	—	—	15.4	—	—	4.4
Testosterone:Cortisol Ratio (Units)	—	—	—	—	59.25	—	—	42.41
Vitamins / minerals
Vitamin D (ng/mL)	—	—	—	—	38.76	31.29	—	35.1
Vitamin B12 (pg/mL)	—	—	—	—	298	—	—	397
Folate (ng/mL)	—	—	—	—	5.73	5.24	—	—
Ferritin (ng/mL)	—	—	—	—	223.3	333	—	250
Iron (ug/dL)	—	—	—	—	115.2	47.82	—	—
TIBC (ug/dL)	—	—	—	—	—	293.07	—	—
Magnesium (mg/dL)	—	—	—	—	2.36	—	—	—
RBC Magnesium (mg/dL)	—	—	—	—	—	—	—	—
Calcium (mg/dL)	—	—	—	—	—	—	—	—
Transferrin saturation (%)	—	—	—	—	—	16.3	—	—
Liver / kidney
ALT (U/L)	—	20	—	—	24.5	25.7	20	26
AST (U/L)	—	—	29	—	—	—	—	24
GGT (U/L)	—	—	—	—	41	47	—	34
Albumin (g/dL)	—	4.8	4.3	—	3.99	4.41	4	—
Creatine kinase (U/L)	—	—	—	—	109	77	—	158
Blood count / immune
Hemoglobin (g/dL)	14.3	14.3	—	—	16.7	15.6	15.1	14.4
Hematocrit (%)	—	43	43	—	47.7	45.8	44.9	43
RBC (x10E6/µL)	4.78	4.69	5	—	4.93	4.84	4.73	4.49
White blood cells (thousands/uL)	7.73	5.39	—	—	9.4	8.3	13.1	7.45
Platelets (thousands/uL)	—	239	268	—	246	258	242	252
Neutrophil count (cells/µL)	—	2,930	4,360	—	5,950	4,490	—	5,059
Monocyte count (cells/µL)	—	390	320	—	720	540	1,010	477
Basophil count (cells/µL)	—	30	40	—	80	50	80	22
Eosinophil count (cells/µL)	—	100	250	—	230	180	200	156
MCH (pg)	—	—	30	—	33.8	32.2	31.9	32.1
MCHC (g/dL)	—	—	—	—	35	34.1	33.6	33.5
MPV (fL)	—	—	—	—	10.1	10.6	—	—
Neutrophil percentage (%)	—	—	—	—	63	54	77	67.9
Eosinophil percentage (%)	—	—	—	—	2	2	2	2.1
Basophil percentage (%)	—	—	—	—	1	1	1	0.3
Lymphocyte percentage (%)	—	—	—	—	25	37	13	23.3
Monocyte percentage (%)	—	—	—	—	8	7	8	6.4
Thyroid
TSH (µIU/L)	—	1.7	1.4	—	2.46	2.7	—	1.91
Brain / electrolytes
Sodium (mmol/L)	143	—	138	—	141	144.9	137	146
Potassium (mmol/L)	4.4	—	3.9	—	5.97	—	4.5	—

Aug 30 2023 – Jul 29 2026

Marker	Aug 30 2023	Jul 03 2024	Jan 17 2025	Aug 11 2025	Apr 08 2026	May 08 2026 ref	May 08 2026 GI	Jul 29 2026	Reference
Heart / lipids
Total Cholesterol (mg/dL)	235	225	—	238	—	—	—	251
HDL Cholesterol (mg/dL)	46	52	—	43	42	—	—	56
LDL Cholesterol (mg/dL)	167	146	—	—	114	—	—	173
Triglycerides (mg/dL)	106	143	—	410	—	—	—	100
ApoB (mg/dL)	125	128	—	135	93	—	—	132
hsCRP (mg/L)	1.3	2.8	—	1.6	1.76	—	—	1.7
Homocysteine (umol/L)	—	—	—	—	—	—	—	16.4
EPA+DPA+DHA (% by wt)	—	—	—	—	—	—	—	2.9
Omega-6/Omega-3 Ratio	—	—	—	—	—	—	—	12.9
Non-HDL Cholesterol (mg/dL)	—	—	—	—	—	—	—	195
LDL Particle Number (nmol/L)	—	—	—	—	—	—	—	1,955
LDL Small (nmol/L)	—	—	—	—	—	—	—	535
LDL Medium (nmol/L)	—	—	—	—	—	—	—	475
LDL Pattern	—	—	—	—	—	—	—	B
LDL Peak Size (Angstrom)	—	—	—	—	—	—	—	215.7
HDL Large (nmol/L)	—	—	—	—	—	—	—	5,141
Lipoprotein(a) (nmol/L)	—	—	—	—	—	—	—	27
Chol/HDL Ratio	—	—	—	—	—	—	—	4.5
AA/EPA Ratio	—	—	—	—	—	—	—	59.1
EPA (% by wt)	—	—	—	—	—	—	—	0.2
DHA (% by wt)	—	—	—	—	—	—	—	1.7
DPA (% by wt)	—	—	—	—	—	—	—	1
Arachidonic Acid (% by wt)	—	—	—	—	—	—	—	13
Linoleic Acid (% by wt)	—	—	—	—	—	—	—	20.4
Omega-6 Total (% by wt)	—	—	—	—	—	—	—	37.2
CRP (mg/L)	—	—	—	—	—	—	—	—
Glucose / metabolism
Glucose (mg/dL)	89	82	—	83	—	77	—	81
HbA1c (%)	5.5	5.2	—	5.3	4.8	—	—	5
Insulin (µIU/mL)	9.5	5.7	—	6.1	—	—	—	3.7
Leptin (ng/mL)	—	—	—	—	—	—	—	1.2
Hormones
Testosterone (ng/dL)	467	730	1,370	1,116	900	—	—	224
Free testosterone (ng/dL)	6.8	10.49	—	16.14	—	—	—	—	PDF free testosterone is 261 pg/mL, a different unit from CSV ng/dL; kept out of trend until converted/confirmed.
SHBG (nmol/L)	37	35	—	30	—	—	—	38
Cortisol (µg/dL)	11.5	8.8	—	10.4	—	—	—	13.3
Testosterone:Cortisol Ratio (Units)	46.09	77.16	—	85.81	—	—	—	—
FSH (mIU/mL)	—	—	—	—	—	—	—	1.1
LH (mIU/mL)	—	—	—	—	—	—	—	0.6
DHEA Sulfate (mcg/dL)	—	—	—	—	—	—	—	300
PSA Total (ng/mL)	—	—	—	—	—	—	—	0.5
Free Testosterone (pg/mL, Quest MS)	—	—	—	—	—	—	—	24.7	46.0-224.0 pg/mL
Bioavailable Testosterone (ng/dL)	—	—	—	—	—	—	—	50.9
Prolactin (ng/mL)	—	—	—	—	—	—	—	6.5
Estradiol (pg/mL)	—	—	—	—	—	—	—	<30
PSA Free (ng/mL)	—	—	—	—	—	—	—	0.2
PSA % Free (%)	—	—	—	—	—	—	—	40
Vitamins / minerals
Vitamin D (ng/mL)	34	31	—	36	35.9	30	—	48
Vitamin B12 (pg/mL)	410	387	—	348	559	—	—	—
Folate (ng/mL)	9.4	7.9	—	8.1	13	—	—	—
Ferritin (ng/mL)	222	144	—	89	193	—	—	269
Iron (ug/dL)	150	137	—	89	48	—	—	141
TIBC (ug/dL)	282	322	—	345	259	—	—	296
Magnesium (mg/dL)	2.3	2.1	—	2.4	2	—	—	2.3
RBC Magnesium (mg/dL)	6.2	5.7	—	4.8	—	—	—	—
Calcium (mg/dL)	9.6	9.3	—	9.8	9.27	—	—	9.6
Methylmalonic Acid (nmol/L)	—	—	—	—	—	—	—	248
Zinc (mcg/dL)	—	—	—	—	—	—	—	78
Lead, Venous (mcg/dL)	—	—	—	—	—	—	—	1.1
Transferrin saturation (%)	53.2	42.5	—	25.8	18.5	—	—	47.6
Liver / kidney
ALT (U/L)	16	19	—	19	27.4	—	—	20
AST (U/L)	13	15	—	17	16	—	—	15
GGT (U/L)	28	35	—	39	42	—	—	40
Albumin (g/dL)	4.6	4.5	—	4.7	4.1	—	—	4.6
Creatine kinase (U/L)	50	56	—	64	—	—	—	—
Creatinine (mg/dL)	—	—	—	—	—	—	—	1.4
eGFR (mL/min/1.73m2)	—	—	—	—	—	—	—	63
Uric Acid (mg/dL)	—	—	—	—	—	—	—	7.5
Alkaline Phosphatase (U/L)	—	—	—	—	—	—	—	50
Bilirubin, Total (mg/dL)	—	—	—	—	—	—	—	0.8
Protein, Total (g/dL)	—	—	—	—	—	—	—	7.1
Globulin (g/dL)	—	—	—	—	—	—	—	2.5
Urea Nitrogen / BUN (mg/dL)	—	—	—	—	—	—	—	16
Albumin/Creatinine Ratio, Urine (mg/g)	—	—	—	—	—	—	—	2
Amylase (U/L)	—	—	—	—	—	—	—	37
Lipase (U/L)	—	—	—	—	—	—	—	17
Blood count / immune
Hemoglobin (g/dL)	15.9	15.8	16	16.8	14.7	—	—	16.4
Hematocrit (%)	45	46.8	47.5	50.9	44.2	—	—	48.9
RBC (x10E6/µL)	5	4.97	—	5.3	4.64	—	—	5.09
White blood cells (thousands/uL)	5.5	6.9	7.7	10.1	10	—	—	5.5
Platelets (thousands/uL)	231	239	245	273	255	—	—	285
Neutrophil count (cells/µL)	3,421	3,988	—	6,898	6,420	—	—	3,586
Monocyte count (cells/µL)	418	704	—	1,111	880	—	—	479
ANA Screen (IFA)	—	—	—	—	—	—	—	POSITIVE
Rheumatoid Factor (IU/mL)	—	—	—	—	—	—	—	<10
MCV (fL)	—	—	—	—	—	—	—	96.1
RDW (%)	—	—	—	—	—	—	—	13
Lymphocyte count (cells/µL)	—	—	—	—	—	—	—	1,298
ABO Group / Rh Type	—	—	—	—	—	—	—	O RhD Positive
Basophil count (cells/µL)	50	62	—	61	120	—	—	50
Eosinophil count (cells/µL)	83	159	—	141	260	—	—	88
MCH (pg)	31.8	31.8	32.8	31.7	31.6	—	—	32.2
MCHC (g/dL)	35.3	33.8	34	33	33.2	—	—	33.5
MPV (fL)	12	11.7	11.7	11.5	9.9	—	—	10.9
Neutrophil percentage (%)	62.2	57.8	—	68.3	64.07	—	—	65.2
Eosinophil percentage (%)	1.5	2.3	—	1.4	2.57	—	—	1.6
Basophil percentage (%)	0.9	0.9	—	0.6	1.24	—	—	0.9
Lymphocyte percentage (%)	27.8	28.8	—	18.7	23.39	—	—	23.6
Monocyte percentage (%)	7.6	10.2	—	11	8.73	—	—	8.7
Thyroid
TSH (µIU/L)	1.4	2.21	—	1.68	2.42	—	—	1.56
T4 Free (ng/dL)	—	—	—	—	—	—	—	1.3
T3 Free (pg/mL)	—	—	—	—	—	—	—	3.1
Thyroid Peroxidase Ab (IU/mL)	—	—	—	—	—	—	—	7
Thyroglobulin Ab (IU/mL)	—	—	—	—	—	—	—	<2
GI / Gut Health
FIT - Fecal Immunochemical Test	—	—	—	—	—	—	Negative (<15 ng/mL)	—	No occult blood detected. Normal: 0-100 ng/mL. Method: Latex quantitative immunochemical assay. Mediclinic Parkview Hospital.
Faecal Calprotectin (µg/g)	—	—	—	—	—	—	9.8	—	Normal <50. Borderline 50-120. Elevated >120. Measures gut inflammation. Method: CLIA. Mediclinic City Hospital.
H. pylori Antigen (Stool)	—	—	—	—	—	—	Negative	—	H. pylori antigens absent. Method: Immunochromatography. Mediclinic Dubai Mall.
Brain / electrolytes
Chloride (mmol/L)	—	—	—	—	—	—	—	104
Carbon Dioxide (mmol/L)	—	—	—	—	—	—	—	23
Sodium (mmol/L)	140	139	—	137	139	—	—	139
Potassium (mmol/L)	4.4	4.3	—	4.1	—	—	—	4.3

Oct 9 2026 – Oct 9 2026

Marker	Oct 9 2026	Reference
Heart / lipids
Total Cholesterol (mg/dL)	163 mg/dL
HDL Cholesterol (mg/dL)	49 mg/dL
LDL Cholesterol (mg/dL)	98 mg/dL
Triglycerides (mg/dL)	69 mg/dL
ApoB (mg/dL)	86 mg/dL
hsCRP (mg/L)	4 mg/L
Homocysteine (umol/L)	9.5 umol/L
EPA+DPA+DHA (% by wt)	4.3 %
Omega-6/Omega-3 Ratio	8.6 ratio
Non-HDL Cholesterol (mg/dL)	114 mg/dL
LDL Particle Number (nmol/L)	853 nmol/L
LDL Small (nmol/L)	153 nmol/L
LDL Medium (nmol/L)	199 nmol/L
LDL Pattern	A
LDL Peak Size (Angstrom)	218 Å
HDL Large (nmol/L)	5809 nmol/L
Lipoprotein(a) (nmol/L)	13 nmol/L
Chol/HDL Ratio	3.3 ratio
AA/EPA Ratio	20.6 ratio
EPA (% by wt)	0.6 %
DHA (% by wt)	2.6 %
DPA (% by wt)	1.2 %
Arachidonic Acid (% by wt)	11.7 %
Linoleic Acid (% by wt)	20.8 %
Omega-6 Total (% by wt)	36.7 %
Glucose / metabolism
Glucose (mg/dL)	80 mg/dL
HbA1c (%)	5.1 %
Insulin (µIU/mL)	3.2 uIU/mL
Leptin (ng/mL)	1.9 ng/mL
Hormones
Testosterone (ng/dL)	1516 ng/dL
SHBG (nmol/L)	30 nmol/L
Cortisol (µg/dL)	9.1 ug/dL
Testosterone:Cortisol Ratio (Units)	Not provided
FSH (mIU/mL)	<0.7
LH (mIU/mL)	0.2 mIU/mL
DHEA Sulfate (mcg/dL)	228 ug/dL
PSA Total (ng/mL)	0.7 ng/mL
Bioavailable Testosterone (ng/dL)	604.4 ng/dL
Prolactin (ng/mL)	8.4 ng/mL
Estradiol (pg/mL)	69 pg/mL
PSA Free (ng/mL)	N/A
PSA % Free (%)	43 %
Vitamins / minerals
Vitamin D (ng/mL)	52 ng/mL
Ferritin (ng/mL)	207 ng/mL
Iron (ug/dL)	75 ug/dL
TIBC (ug/dL)	215 ug/dL
Magnesium (mg/dL)	2 mg/dL
Calcium (mg/dL)	9.3 mg/dL
Methylmalonic Acid (nmol/L)	250 nmol/L
Zinc (mcg/dL)	69 ug/dL
Lead, Venous (mcg/dL)	<1
Transferrin saturation (%)	35 %
Liver / kidney
ALT (U/L)	16 U/L
AST (U/L)	14 U/L
GGT (U/L)	28 U/L
Albumin (g/dL)	4.1 g/dL
Creatinine (mg/dL)	1.29 mg/dL
eGFR (mL/min/1.73m2)	69 mL/min/1.73m2
Uric Acid (mg/dL)	5.3 mg/dL
Alkaline Phosphatase (U/L)	44 U/L
Bilirubin, Total (mg/dL)	0.4 mg/dL
Protein, Total (g/dL)	6.3 g/dL
Globulin (g/dL)	2.2 g/dL
Urea Nitrogen / BUN (mg/dL)	12 mg/dL
Albumin/Creatinine Ratio, Urine (mg/g)	1 mg/g creat
Amylase (U/L)	35 U/L
Lipase (U/L)	16 U/L
Blood count / immune
Hemoglobin (g/dL)	14 g/dL
Hematocrit (%)	42.5 %
RBC (x10E6/µL)	4.49 million/uL
White blood cells (thousands/uL)	8.6 K/uL
Platelets (thousands/uL)	259 K/uL
Neutrophil count (cells/µL)	5401 cells/uL
Monocyte count (cells/µL)	791 cells/uL
ANA Screen (IFA)	POSITIVE
Rheumatoid Factor (IU/mL)	<10
MCV (fL)	94.7 fL
RDW (%)	12.1 %
Lymphocyte count (cells/µL)	2227 cells/uL
Basophil count (cells/µL)	60 cells/uL
Eosinophil count (cells/µL)	120 cells/uL
MCH (pg)	31.2 pg
MCHC (g/dL)	32.9 g/dL
MPV (fL)	11.3 fL
Neutrophil percentage (%)	62.8 %
Eosinophil percentage (%)	1.4 %
Basophil percentage (%)	0.7 %
Lymphocyte percentage (%)	25.9 %
Monocyte percentage (%)	9.2 %
Thyroid
T4 Free (ng/dL)	1.4 ng/dL
T3 Free (pg/mL)	3.3 pg/mL
Thyroid Peroxidase Ab (IU/mL)	5 IU/mL
Thyroglobulin Ab (IU/mL)	<2
Brain / electrolytes
Chloride (mmol/L)	105 mmol/L
Carbon Dioxide (mmol/L)	23 mmol/L
Sodium (mmol/L)	140 mmol/L
Potassium (mmol/L)	4.1 mmol/L
Additional panel markers
PTFQI ({Index_val})	0.47 {Index_val}
FT3/FT4 Ratio (ratio)	0.28 ratio
SPINA-GT (pmol/s)	3.61 pmol/s
SPINA-GD (nmol/s)	26.1 nmol/s
Ferritin (Adj. for Inflammation) (ng/mL)	142.68 ng/mL
RW-ApoB (mg/dL)	75.2 mg/dL
eGFR (creatinine + cystatin C) (mL/min/1.73m2)	78.26 mL/min/1.73m2
Anion Gap (mmol/L)	12 mmol/L
UIBC (ug/dL)	140 ug/dL
Triglyceride/HDL Ratio (ratio)	1.41 ratio
LDL/HDL Ratio (ratio)	2 ratio
Copper (Serum) (ug/dL)	88 ug/dL
Mercury (Blood) (ug/L)	<4
Free Testosterone (Calculated) (pg/mL)	321.1 pg/mL
Omega-3 Total (%)	4.3 %
Cystatin C (mg/L)	0.99 mg/L
eGFR (cystatin C) (mL/min/1.73m2)	83 mL/min/1.73m2
TSH (uIU/mL)	1.68 uIU/mL
ANA Titer (titer)	1:80
ANA Pattern (pattern)	Nuclear, Speckled
Creatinine, Urine (mg/dL)	220 mg/dL
Microalbumin Urine (mg/dL)	N/A
BUN/Creatinine Ratio (ratio)	SEE NOTE:
Albumin/Globulin Ratio (ratio)	1.9 ratio
Ceruloplasmin (mg/dL)	22 mg/dL

Appendix B — Blood Pressure Log

Date	Time	Systolic	Diastolic	Pulse pressure	Pulse
Aug 15 2026	14:33 UTC	117	77	40	—
Aug 05 2026	12:59 UTC	143	45	98	—

Appendix C — Data Sources

/root/.openclaw/workspace/My Health Files/MRN 13987 - PREMIUM PLUS MEN HEALTH SCREENING.pdf
/root/.openclaw/workspace/My Health Files/bloodwork_history.csv
Blueprint/Bryan Johnson biomarkers export (verified against source labs 2026-08-15)
InsideTracker screenshot supplied 2026-05-08
Quest Diagnostics Lab Report collected Jul 29 2026
Quest Diagnostics specimen ZD664970N, collected 2026-07-29, reported 2026-08-12 (full 12-page report)
Photo inventory 2026-08-24 13:04 UTC — 36 products (health/inventory-2026-08-24)
Oura app screenshot 2026-08-24 ~13:14 local — Readiness 45 / Sleep 45 / Activity 36 / HR 79
Oura API v2 sync 2026-08-24 15:31 UTC
Oura API v2 sync 2026-08-25 04:30 UTC
Oura API v2 sync 2026-08-26 04:31 UTC
Ian pasted HGH assessment 2026-08-26 — advisory notes and baseline/follow-up monitoring panel
Explicit day/night supplement split agreed 2026-08-24; testosterone dose clarified 2026-08-26
Oura API v2 sync 2026-08-26 13:07 UTC
Oura API v2 sync 2026-08-26 14:36 UTC
Oura API v2 sync 2026-08-26 20:01 UTC
Oura API v2 sync 2026-08-27 04:30 UTC
Oura API v2 sync 2026-08-27 08:01 UTC
Oura API v2 sync 2026-08-27 13:00 UTC
Oura API v2 sync 2026-08-27 20:00 UTC
Oura API v2 sync 2026-08-28 04:31 UTC
Oura API v2 sync 2026-08-28 08:00 UTC
Oura API v2 sync 2026-08-28 13:01 UTC
Oura API v2 sync 2026-08-28 20:01 UTC
Oura API v2 sync 2026-08-29 04:31 UTC
Oura API v2 sync 2026-08-29 08:00 UTC
Oura API v2 sync 2026-08-29 13:00 UTC
Oura API v2 sync 2026-08-29 20:00 UTC
Oura API v2 sync 2026-08-30 04:31 UTC
Oura API v2 sync 2026-08-30 08:00 UTC
Oura API v2 sync 2026-08-30 13:00 UTC
Oura API v2 sync 2026-08-30 20:00 UTC
Oura API v2 sync 2026-08-31 04:31 UTC
Oura API v2 sync 2026-08-31 08:00 UTC
Oura API v2 sync 2026-08-31 13:01 UTC
Oura API v2 sync 2026-08-31 20:01 UTC
Oura API v2 sync 2026-09-01 04:31 UTC
Oura API v2 sync 2026-09-01 08:00 UTC
Oura API v2 sync 2026-09-01 13:01 UTC
Oura API v2 sync 2026-09-01 20:00 UTC
Oura API v2 sync 2026-09-02 04:30 UTC
Oura API v2 sync 2026-09-02 08:01 UTC
Oura API v2 sync 2026-09-02 13:00 UTC
Oura API v2 sync 2026-09-02 20:00 UTC
Oura API v2 sync 2026-09-03 04:30 UTC
Oura API v2 sync 2026-09-03 08:01 UTC
Oura API v2 sync 2026-09-03 13:00 UTC
Oura API v2 sync 2026-09-03 20:00 UTC
Oura API v2 sync 2026-09-04 04:30 UTC
Oura API v2 sync 2026-09-04 08:01 UTC
Oura API v2 sync 2026-09-04 13:00 UTC
Oura API v2 sync 2026-09-04 20:01 UTC
Oura API v2 sync 2026-09-05 04:30 UTC
Oura API v2 sync 2026-09-05 08:00 UTC
Oura API v2 sync 2026-09-05 13:00 UTC
Oura API v2 sync 2026-09-05 20:00 UTC
Oura API v2 sync 2026-09-06 04:31 UTC
Oura API v2 sync 2026-09-06 08:00 UTC
Oura API v2 sync 2026-09-06 13:01 UTC
Oura API v2 sync 2026-09-06 20:01 UTC
Oura API v2 sync 2026-09-07 04:30 UTC
Oura API v2 sync 2026-09-07 08:01 UTC
Oura API v2 sync 2026-09-07 13:00 UTC
Oura API v2 sync 2026-09-07 20:00 UTC
Oura API v2 sync 2026-09-08 04:30 UTC
Oura API v2 sync 2026-09-08 08:00 UTC
Oura API v2 sync 2026-09-08 13:00 UTC
Oura API v2 sync 2026-09-08 20:00 UTC
Oura API v2 sync 2026-09-09 04:30 UTC
Oura API v2 sync 2026-09-09 08:00 UTC
Oura API v2 sync 2026-09-09 13:01 UTC
Oura API v2 sync 2026-09-09 20:01 UTC
Oura API v2 sync 2026-09-10 04:30 UTC
Oura API v2 sync 2026-09-10 08:01 UTC
Oura API v2 sync 2026-09-10 13:01 UTC
Oura API v2 sync 2026-09-10 20:00 UTC
Oura API v2 sync 2026-09-11 04:31 UTC
Oura API v2 sync 2026-09-11 08:00 UTC
Oura API v2 sync 2026-09-11 13:01 UTC
Oura API v2 sync 2026-09-11 20:00 UTC
Oura API v2 sync 2026-09-12 04:30 UTC
Oura API v2 sync 2026-09-12 08:01 UTC
Oura API v2 sync 2026-09-12 13:00 UTC
Oura API v2 sync 2026-09-12 20:00 UTC
Oura API v2 sync 2026-09-13 04:31 UTC
Oura API v2 sync 2026-09-13 08:00 UTC
Oura API v2 sync 2026-09-13 13:00 UTC
Oura API v2 sync 2026-09-13 20:01 UTC
Oura API v2 sync 2026-09-14 04:30 UTC
Oura API v2 sync 2026-09-14 08:01 UTC
Oura API v2 sync 2026-09-14 13:00 UTC
Oura API v2 sync 2026-09-14 20:00 UTC
Oura API v2 sync 2026-09-15 04:30 UTC
Oura API v2 sync 2026-09-15 08:00 UTC
Oura API v2 sync 2026-09-15 13:00 UTC
Oura API v2 sync 2026-09-15 20:00 UTC
Oura API v2 sync 2026-09-16 04:31 UTC
Oura API v2 sync 2026-09-16 08:00 UTC
Oura API v2 sync 2026-09-16 13:00 UTC
Oura API v2 sync 2026-09-16 20:00 UTC
Oura API v2 sync 2026-09-17 04:30 UTC
Oura API v2 sync 2026-09-17 08:00 UTC
Oura API v2 sync 2026-09-17 13:00 UTC
Oura API v2 sync 2026-09-17 20:00 UTC
Oura API v2 sync 2026-09-18 04:31 UTC
Oura API v2 sync 2026-09-18 08:00 UTC
Oura API v2 sync 2026-09-18 13:00 UTC
Oura API v2 sync 2026-09-18 20:01 UTC
Oura API v2 sync 2026-09-19 04:30 UTC
Oura API v2 sync 2026-09-19 08:00 UTC
Oura API v2 sync 2026-09-19 13:01 UTC
Oura API v2 sync 2026-09-19 20:00 UTC
Oura API v2 sync 2026-09-20 04:30 UTC
Oura API v2 sync 2026-09-20 08:01 UTC
Oura API v2 sync 2026-09-20 13:00 UTC
Oura API v2 sync 2026-09-20 20:01 UTC
Oura API v2 sync 2026-09-21 04:30 UTC
Oura API v2 sync 2026-09-21 08:00 UTC
Oura API v2 sync 2026-09-21 13:01 UTC
Oura API v2 sync 2026-09-21 20:01 UTC
Oura API v2 sync 2026-09-22 04:30 UTC
Oura API v2 sync 2026-09-22 08:00 UTC
Oura API v2 sync 2026-09-22 13:01 UTC
Oura API v2 sync 2026-09-22 20:00 UTC
Oura API v2 sync 2026-09-23 04:31 UTC
Oura API v2 sync 2026-09-23 08:00 UTC
Oura API v2 sync 2026-09-23 13:00 UTC
Oura API v2 sync 2026-09-23 20:00 UTC
Oura API v2 sync 2026-09-24 04:30 UTC
Oura API v2 sync 2026-09-24 08:01 UTC
Oura API v2 sync 2026-09-24 13:00 UTC
Oura API v2 sync 2026-09-24 20:01 UTC
Oura API v2 sync 2026-09-25 04:30 UTC
Oura API v2 sync 2026-09-25 08:00 UTC
Oura API v2 sync 2026-09-25 13:00 UTC
Oura API v2 sync 2026-09-25 20:01 UTC
Oura API v2 sync 2026-09-26 04:30 UTC
Oura API v2 sync 2026-09-26 08:01 UTC
Oura API v2 sync 2026-09-26 13:00 UTC
Oura API v2 sync 2026-09-26 20:00 UTC
Oura API v2 sync 2026-09-27 04:30 UTC
Oura API v2 sync 2026-09-27 08:01 UTC
Oura API v2 sync 2026-09-27 13:00 UTC
Oura API v2 sync 2026-09-27 20:01 UTC
Oura API v2 sync 2026-09-28 04:30 UTC
Oura API v2 sync 2026-09-28 08:00 UTC
Oura API v2 sync 2026-09-28 13:00 UTC
Oura API v2 sync 2026-09-28 20:01 UTC
Oura API v2 sync 2026-09-29 04:30 UTC
Oura API v2 sync 2026-09-29 08:00 UTC
Oura API v2 sync 2026-09-29 13:00 UTC
Oura API v2 sync 2026-09-29 20:01 UTC
Oura API v2 sync 2026-09-30 04:30 UTC
Oura API v2 sync 2026-09-30 08:01 UTC
Oura API v2 sync 2026-09-30 13:00 UTC
Oura API v2 sync 2026-09-30 20:00 UTC
Oura API v2 sync 2026-10-01 04:31 UTC
Oura API v2 sync 2026-10-01 08:01 UTC
Oura API v2 sync 2026-10-01 13:01 UTC
Oura API v2 sync 2026-10-01 20:00 UTC
Oura API v2 sync 2026-10-02 04:31 UTC
Oura API v2 sync 2026-10-02 08:01 UTC
Oura API v2 sync 2026-10-02 13:00 UTC
Oura API v2 sync 2026-10-02 20:00 UTC
Oura API v2 sync 2026-10-03 04:30 UTC
Oura API v2 sync 2026-10-03 08:01 UTC
Oura API v2 sync 2026-10-03 13:01 UTC
Oura API v2 sync 2026-10-03 20:01 UTC
Oura API v2 sync 2026-10-04 04:31 UTC
Oura API v2 sync 2026-10-04 08:01 UTC
Oura API v2 sync 2026-10-04 13:01 UTC
Oura API v2 sync 2026-10-04 20:01 UTC
Oura API v2 sync 2026-10-05 04:31 UTC
Oura API v2 sync 2026-10-05 08:00 UTC
Oura API v2 sync 2026-10-05 13:01 UTC
Oura API v2 sync 2026-10-05 20:00 UTC
Oura API v2 sync 2026-10-06 04:30 UTC
Oura API v2 sync 2026-10-06 08:01 UTC
Oura API v2 sync 2026-10-06 13:00 UTC
Oura API v2 sync 2026-10-06 20:00 UTC
Oura API v2 sync 2026-10-07 04:31 UTC
Oura API v2 sync 2026-10-07 08:01 UTC
Oura API v2 sync 2026-10-07 13:01 UTC
Oura API v2 sync 2026-10-07 20:00 UTC
Oura API v2 sync 2026-10-08 04:30 UTC
Oura API v2 sync 2026-10-08 08:01 UTC
Oura API v2 sync 2026-10-08 13:00 UTC
Oura API v2 sync 2026-10-08 20:01 UTC
Oura API v2 sync 2026-10-09 04:31 UTC
Oura API v2 sync 2026-10-09 08:01 UTC
Oura API v2 sync 2026-10-09 13:01 UTC
Oura API v2 sync 2026-10-09 20:00 UTC
Oura API v2 sync 2026-10-10 13:01 UTC
Oura API v2 sync 2026-10-10 20:00 UTC
Oura API v2 sync 2026-10-11 04:30 UTC
Oura API v2 sync 2026-10-11 08:00 UTC
Oura API v2 sync 2026-10-11 13:00 UTC
Oura API v2 sync 2026-10-11 20:00 UTC
Oura API v2 sync 2026-10-12 04:30 UTC
Oura API v2 sync 2026-10-12 08:00 UTC
Oura API v2 sync 2026-10-12 13:00 UTC
Oura API v2 sync 2026-10-12 20:00 UTC
Oura API v2 sync 2026-10-13 04:30 UTC
Oura API v2 sync 2026-10-13 08:00 UTC
Oura API v2 sync 2026-10-13 13:01 UTC
Oura API v2 sync 2026-10-13 20:00 UTC
Oura API v2 sync 2026-10-14 04:31 UTC
Oura API v2 sync 2026-10-14 08:01 UTC
Oura API v2 sync 2026-10-14 13:00 UTC
Oura API v2 sync 2026-10-14 20:00 UTC
Oura API v2 sync 2026-10-15 04:30 UTC
Oura API v2 sync 2026-10-15 08:01 UTC
Oura API v2 sync 2026-10-15 13:00 UTC
Oura API v2 sync 2026-10-15 20:00 UTC
Oura API v2 sync 2026-10-16 04:30 UTC
Oura API v2 sync 2026-10-16 08:00 UTC
Oura API v2 sync 2026-10-16 13:00 UTC
Oura API v2 sync 2026-10-16 20:00 UTC
Oura API v2 sync 2026-10-17 04:30 UTC
Oura API v2 sync 2026-10-17 08:00 UTC
Oura API v2 sync 2026-10-17 13:01 UTC
Oura API v2 sync 2026-10-17 20:00 UTC
Oura API v2 sync 2026-10-18 04:30 UTC
Oura API v2 sync 2026-10-18 08:00 UTC
Oura API v2 sync 2026-10-18 13:01 UTC
Oura API v2 sync 2026-10-18 20:00 UTC
Oura API v2 sync 2026-10-19 04:30 UTC
Oura API v2 sync 2026-10-19 08:01 UTC
Oura API v2 sync 2026-10-19 13:01 UTC
Oura API v2 sync 2026-10-19 20:00 UTC
Oura API v2 sync 2026-10-20 04:30 UTC
Oura API v2 sync 2026-10-20 08:00 UTC
Oura API v2 sync 2026-10-20 13:01 UTC
Oura API v2 sync 2026-10-20 20:01 UTC
Oura API v2 sync 2026-10-21 04:31 UTC
Oura API v2 sync 2026-10-21 08:00 UTC
Oura API v2 sync 2026-10-21 13:00 UTC
Oura API v2 sync 2026-10-21 20:01 UTC
Oura API v2 sync 2026-10-22 04:30 UTC
Oura API v2 sync 2026-10-22 08:00 UTC
Oura API v2 sync 2026-10-22 13:01 UTC
Oura API v2 sync 2026-10-22 20:00 UTC
Oura API v2 sync 2026-10-23 04:31 UTC
Oura API v2 sync 2026-10-23 08:00 UTC
Oura API v2 sync 2026-10-23 13:00 UTC
Oura API v2 sync 2026-10-23 20:00 UTC
Oura API v2 sync 2026-10-24 04:31 UTC
Oura API v2 sync 2026-10-24 08:01 UTC
Oura API v2 sync 2026-10-24 13:00 UTC
Oura API v2 sync 2026-10-24 20:01 UTC
Oura API v2 sync 2026-10-25 04:30 UTC
Oura API v2 sync 2026-10-25 08:00 UTC
Oura API v2 sync 2026-10-25 13:00 UTC
Oura API v2 sync 2026-10-25 20:00 UTC
Oura API v2 sync 2026-10-26 04:31 UTC
Oura API v2 sync 2026-10-26 08:01 UTC
Oura API v2 sync 2026-10-26 13:00 UTC
Oura API v2 sync 2026-10-26 20:01 UTC
Oura API v2 sync 2026-10-27 04:31 UTC
Oura API v2 sync 2026-10-27 08:00 UTC
Oura API v2 sync 2026-10-27 13:01 UTC
Oura API v2 sync 2026-10-27 20:00 UTC
Oura API v2 sync 2026-10-28 04:31 UTC
Oura API v2 sync 2026-10-28 08:01 UTC
Oura API v2 sync 2026-10-28 13:01 UTC
Goodlabs/Quest; collected 2026-10-09; order 24957290-c743-4160-ba39-70f0c79ab943; user-supplied 122-marker dump.
Goodlabs/Quest order 24957290-c743-4160-ba39-70f0c79ab943, collected 2026-10-09 (full panel)
Oura API v2 sync 2026-10-28 20:00 UTC
Oura API v2 sync 2026-10-29 04:30 UTC
Oura API v2 sync 2026-10-29 08:01 UTC
Oura API v2 sync 2026-10-29 13:00 UTC
Oura API v2 sync 2026-10-29 20:00 UTC
Oura API v2 sync 2026-10-30 04:31 UTC
Oura API v2 sync 2026-10-30 08:00 UTC
Oura API v2 sync 2026-10-30 13:01 UTC
Oura API v2 sync 2026-10-30 20:00 UTC
Oura API v2 sync 2026-10-31 04:31 UTC
Oura API v2 sync 2026-10-31 08:00 UTC
Oura API v2 sync 2026-10-31 13:01 UTC
Oura API v2 sync 2026-10-31 20:00 UTC
Oura API v2 sync 2026-11-01 04:30 UTC
Oura API v2 sync 2026-11-01 08:00 UTC
Oura API v2 sync 2026-11-01 13:01 UTC
Oura API v2 sync 2026-11-01 20:00 UTC
Oura API v2 sync 2026-11-02 04:30 UTC
Oura API v2 sync 2026-11-02 08:01 UTC
Oura API v2 sync 2026-11-02 13:01 UTC
Oura API v2 sync 2026-11-02 20:00 UTC

134 markers across 17 draws, Aug 20 2004 to Oct 9 2026. Compiled 2026-11-02.

Health Report

Latest panel — Oct 9 2026

Historical Executive Summary

Key Findings

Priority Actions

Historical Context

Oura

Readiness

Sleep

Activity

Heart rate

Active calories

Current Supplement Stack

☀️ Day — With Breakfast

🌙 Night — Before Bed

As-Needed / Rotate

Injectables / research-labelled

HGH assessment — advisory notes

Current read

Baseline before any clinician-directed HGH

Suggested follow-up if prescribed

Inventory log — 36 products

What changed vs the last site stack

Counts

Adjust Stack Based on Bloods

Lipid Profile

Vitamins & Minerals

Liver Function

Kidney Function

Hematocrit / Red Cells

Historical Watchlist — Jul 29 2026

Blood Pressure

Blood Pressure (mmHg)

Heart / lipids

Total Cholesterol (mg/dL)

HDL Cholesterol (mg/dL)

LDL Cholesterol (mg/dL)

Triglycerides (mg/dL)

ApoB (mg/dL)

hsCRP (mg/L)

Homocysteine (umol/L)

EPA+DPA+DHA (% by wt)

Omega-6/Omega-3 Ratio

Non-HDL Cholesterol (mg/dL)

LDL Particle Number (nmol/L)

LDL Small (nmol/L)

LDL Medium (nmol/L)

LDL Pattern

LDL Peak Size (Angstrom)

HDL Large (nmol/L)

Lipoprotein(a) (nmol/L)

Chol/HDL Ratio

AA/EPA Ratio

EPA (% by wt)

DHA (% by wt)

DPA (% by wt)

Arachidonic Acid (% by wt)

Linoleic Acid (% by wt)

Omega-6 Total (% by wt)

CRP (mg/L)

Glucose / metabolism

Glucose (mg/dL)

HbA1c (%)

Insulin (µIU/mL)

Leptin (ng/mL)

Hormones

Testosterone (ng/dL)

Free testosterone (ng/dL)

SHBG (nmol/L)

Cortisol (µg/dL)

Testosterone:Cortisol Ratio (Units)

FSH (mIU/mL)

LH (mIU/mL)

DHEA Sulfate (mcg/dL)

PSA Total (ng/mL)

Free Testosterone (pg/mL, Quest MS)

Bioavailable Testosterone (ng/dL)

Prolactin (ng/mL)

Estradiol (pg/mL)

PSA Free (ng/mL)